Drug Approval | November 08, 2022
Zydus receives EIR with VAI from USFDA for Moraiya facility
The USFDA has determined that the inspection classification of the facility is Voluntary Action Indicated (VAI)
The USFDA has determined that the inspection classification of the facility is Voluntary Action Indicated (VAI)
AB PMJAY has been successful in providing quality health services to the beneficiaries who come from weak financial backgrounds
Norliqva was approved by the FDA on February 24, 2022 and is now available through normal retail distribution.
The drug will be available in 600 hospitals and 105 DTPs
Three RFPs now open for qualified researchers through NORD's Jayne Holtzer rare disease research grants program
With this move, government hospitals across India can now access the geko device to prevent life-threatening blood clots, and address complications related to swelling following orthopaedic surgery and the healing of chronic wounds (leg ulcers)
Colorectal Cancer Screening is now translated into multiple languages to help people worldwide understand why, when and how to screen for colorectal cancer
The company is Series A funded with US $ 7 million in funding so far
Breakthrough formulation helps reduce the risk of exposure using a non-hazardous formulation and leakproof format during transport and processing
It is the first U.S. FDA approved novel topical mechanism for acne in nearly 40 years
Subscribe To Our Newsletter & Stay Updated
